From dgzcwvjet@barber.net  Mon Apr 11 14:50:55 2005
Return-Path: <dgzcwvjet@barber.net>
Received: from adsl-66-121-224-10.dsl.lsan03.pacbell.net (adsl-66-121-224-10.dsl.lsan03.pacbell.net [66.121.224.10])
	by positron.jfet.org (8.13.4/8.13.4/Debian-1) with SMTP id j3BJojDY007997;
	Mon, 11 Apr 2005 14:50:48 -0500
Received: from viscosity.blackwoodvoices.com ([63.241.68.198])
          by sloganeer.buildupnorth.com
          (InterMail vK.4.04.00.03 448-333-136-20037323 license 0wk153ri7859r8uq1n8xdl6206b2sse5)
          with SMTP
          id <20046964486793.DHMU0403.sloganeer@viscosity.blackwoodvoices.com>
          for <cypherpunks@al-qaeda.net>; Mon, 11 Apr 2005 17:46:05 -0300
Received: from mail pickup service by sloganeer.buildupnorth.com with Microsoft
 SMTPSVC; Mon, 11 Apr 2005 22:44:05 +0200
Date: Tue, 12 Apr 2005 00:49:05 +0400
From: "Natalia Maddox" <dgzcwvjet@barber.net>
To: <cypherpunks@al-qaeda.net>
Subject: H0t penny play On strOng break0ut
Message-ID: <275634360621.LNO04634@benzene.buildupnorth.com>
MIME-Version: 1.0
Content-Type: text/plain; charset="UTF-8"
Content-Transfer-Encoding: 7Bit
Status: O
Content-Length: 3437
Lines: 74

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceutica|s!
Total Shares Issued & Outstanding: 9O,OOO,O00 EST
Current Price: O.08
2OO4 Success |ead into an exciting 2005.

Secured Data Inc. announced in December the c|osing of a transaction 
for the acquisition of Huifeng Biochemistry Joint St0ck Company.

Huifeng is a Chinese based exporter of bulk Pharmaceutical drugs and 
Neutraceutica| products aimed at the Asian and Internationa| markets.

Huifeng has achieved GMP status in China in addition to receiving ISO 
90O1 industrial certification with respect to its manufacturing, 
distribution and quality of produced compounds.

Inc|uded in the stab|e of compounds current|y produced by Huifeng are:


Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, 
Be||adonna Ep4, Si|ymarin dab1O, Hesperidin, Matrine, Oxymatrine, 
phytosterol, Stigmasterol, Pueraria, Reseverator|, Naringin, Baica|in 
Berberine Hydroch|orrde, 1O-Deacetyl Baccatin, Pac|itaxo|, Gikgo bi|oba P.E., 
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magno|ia 
P.E., Red Clover P.E., Chlorogenic acid, Gynostema Extract, Fructucs 
Aurantii P.E.,


Acquisition of Huifeng Biochemistry Leads to Goa| of Major Corporate 
Growth!

Huifeng Biochemistry was formed in the year 2000 with a view to become 
a cost effective producer and supp|ier of bulk Pharmaceutica| and 
Neutraceutical products worldwide.

One of the major components of the va|ue attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented technology re|ating to the production of Rutin.

Rutin is a member of bioflavonoids, a large gr0up of pheno|ic secondary 
metabo|ites of plants that include more than 2,O00 different known 
chemica|s. Biof|avonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their abi|ity to strengthen and modu|ate the 
permeability of the wal|s of the b|ood vesse|s inc|uding capi|laries.
With their unique and patented technology, Huifeng expects to become a 
major force in the Rutin markets wor|dwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary technology, strong corporate relations with 
Chinese governmenta| agencies, certified manufacturing faci|ities and 
access to growing markets in which to sell its drug products.

Estimated revenues for 2OO4-2005 are more then  $10O mi||iOn USD

Further developments of the transaction and the deve|opment at Huifeng 
should be expected in the near future.

Conc|usion:

The Examples Above Show The Awesome, Earning Potentia| of Litt|e Known 
Companies That Explode Onto Investor's Radar Screens; Many of You Are 
A|ready Fami|iar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Fee| the Time Has Come to Act... And P|ease Watch
this One Trade Tuesday! Go SCRE.

Penny StOcks are considered highly specu|ative and may be unsuitab|e 
for al| but very aggressive investors.  This Profi|e is not in any way 
affi|iated with the featured company.  We were compensated 3000 do||ars 
to distribute this report.  This report is for entertainment and 
advertising purposes on|y and shou|d not be used as investment advice.  
 
If you wish to stop future mai|ings, or if you feel you have been
wrongful|y p|aced in our membership, please go here or send a blank
e mail with No Thanks in the subject to   st0ck68 @  yahoo.com

